Literature DB >> 16208022

Endophthalmitis caused by Fusarium proliferatum.

Consuelo Ferrer1, Jorge Alio, Alejandra Rodriguez, Mariano Andreu, Francisca Colom.   

Abstract

Fusarium proliferatum caused endophthalmitis after cataract surgery. Diagnosis was established by classical microbiology and molecular biology methods (PCR and DNA typing). The treatment with local amphotericin B, oral ketoconazole, and topical natamycin was successful.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16208022      PMCID: PMC1248518          DOI: 10.1128/JCM.43.10.5372-5375.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens.

Authors:  N A Rotowa; H J Shadomy; S Shadomy
Journal:  Mycoses       Date:  1990-04       Impact factor: 4.377

2.  Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method.

Authors:  A Reuben; E Anaissie; P E Nelson; R Hashem; C Legrand; D H Ho; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  Mycotic keratitis in South Florida: a review of thirty-nine cases.

Authors:  D B Jones; R Sexton; G Rebell
Journal:  Trans Ophthalmol Soc U K       Date:  1970

Review 4.  Successful treatment of disseminated Fusarium infection in an immunocompromised child.

Authors:  N J Barrios; D V Kirkpatrick; A Murciano; K Stine; R B Van Dyke; J R Humbert
Journal:  Am J Pediatr Hematol Oncol       Date:  1990

Review 5.  Case report and review of resolved fusariosis.

Authors:  T N Helm; D L Longworth; G S Hall; B J Bolwell; B Fernandez; K J Tomecki
Journal:  J Am Acad Dermatol       Date:  1990-08       Impact factor: 11.527

6.  Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods.

Authors:  Maria José Linares; Guadalupe Charriel; Francisco Solís; Fernando Rodriguez; Ana Ibarra; M Casal
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  Fusarium solani endophthalmitis without primary corneal involvement.

Authors:  T W Lieberman; A P Ferry; E J Bottone
Journal:  Am J Ophthalmol       Date:  1979-10       Impact factor: 5.258

8.  Invasive Fusarium solani infections in patients with acute leukemia.

Authors:  M Venditti; A Micozzi; G Gentile; L Polonelli; G Morace; P Bianco; G Avvisati; G Papa; P Martino
Journal:  Rev Infect Dis       Date:  1988 May-Jun

9.  Fusarium proliferatum as an agent of disseminated infection in an immunosuppressed patient.

Authors:  R C Summerbell; S E Richardson; J Kane
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

10.  Exogenous fungal endophthalmitis.

Authors:  S C Pflugfelder; H W Flynn; T A Zwickey; R K Forster; A Tsiligianni; W W Culbertson; S Mandelbaum
Journal:  Ophthalmology       Date:  1988-01       Impact factor: 12.079

View more
  14 in total

1.  Fusarium sacchari: a cause of exogenous fungal endophthalmitis: first case report and review of literature.

Authors:  Jagdish Chander; Nidhi Singla; Neelam Gulati; Sunandan Sood
Journal:  Mycopathologia       Date:  2010-10-24       Impact factor: 2.574

Review 2.  Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here?

Authors:  S A Balajee; A M Borman; M E Brandt; J Cano; M Cuenca-Estrella; E Dannaoui; J Guarro; G Haase; C C Kibbler; W Meyer; K O'Donnell; C A Petti; J L Rodriguez-Tudela; D Sutton; A Velegraki; B L Wickes
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

3.  Fusarium proliferatum soft tissue infection at the site of a puncture by a plant: recovery, isolation, and direct molecular identification.

Authors:  Tara N Palmore; Yvonne R Shea; Richard W Childs; Richard M Sherry; Thomas J Walsh
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

4.  Outbreak of fungal endophthalmitis due to Fusarium oxysporum following cataract surgery.

Authors:  Vladimír Buchta; Alena Feuermannová; Martin Váša; Lenka Bašková; Radka Kutová; Alena Kubátová; Marcela Vejsová
Journal:  Mycopathologia       Date:  2014-01-01       Impact factor: 2.574

5.  Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.

Authors:  Ananya Tupaki-Sreepurna; Vijayakishore Thanneru; Sangeetha Natarajan; Savitri Sharma; Anjana Gopi; Murugan Sundaram; Anupma Jyoti Kindo
Journal:  Mycopathologia       Date:  2018-02-14       Impact factor: 2.574

6.  A Case of Fungus Ball-Type Pansinusitis Due to Fusarium proliferatum.

Authors:  Seyed Jamal Hashemi; Mojtaba Mohammadi Ardehali; Sassan Rezaie; Ensieh Zibafar; Mohseh Gerami Shoar; Ali Rezaei-Matehkolaei; Hassan Ehteram; Mohammad Javad Najafzadeh; Mehdi Nazeri
Journal:  Mycopathologia       Date:  2015-05-30       Impact factor: 2.574

Review 7.  Urinary Tract Infection (UTI) Caused by Fusarium proliferatum in an Agranulocytosis Patient and a Review of Published Reports.

Authors:  Huilin Su; Qiangqiang Zhang; Li Li; Ying Zhao; Junhao Zhu; Min Zhu
Journal:  Mycopathologia       Date:  2015-09-07       Impact factor: 2.574

Review 8.  Fusarium infections in immunocompromised patients.

Authors:  Marcio Nucci; Elias Anaissie
Journal:  Clin Microbiol Rev       Date:  2007-10       Impact factor: 26.132

9.  Successful salvage therapy of Fusarium endophthalmitis secondary to keratitis: an interventional case series.

Authors:  Grant M Comer; Maxwell S Stem; Stephen J Saxe
Journal:  Clin Ophthalmol       Date:  2012-05-09

10.  Use of multiple methods for genotyping Fusarium during an outbreak of contact lens associated fungal keratitis in Singapore.

Authors:  Roland Jureen; Tse H Koh; Grace Wang; Louis Y A Chai; Ai L Tan; Tracy Chai; Yong W Wong; Yue Wang; Paul A Tambyah; Roger Beuerman; Donald Tan
Journal:  BMC Infect Dis       Date:  2008-07-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.